Our data support this distinction: galectin-3 was more prominently associated with the severity of coronary stenosis, whereas pentraxin-3 showed variable expression across AF subtypes, potentially reflecting dynamic endothelial or inflammatory activation rather than a fixed fibrotic state. This evidence concerns the gene LGALS3 and atrial fibrillation.